Updated July 2026 · 8 min read

Sugammadex vs Neostigmine — Reversing Paralysis at the Bedside

Part of the ICU Emergencies Hub — browse every related guide in one place.

When a patient has been given a nondepolarizing paralytic like rocuronium or vecuronium — for intubation, surgery, or a period of deep sedation — someone eventually has to reverse it. There are two very different ways to do that, and the choice shapes what you monitor. Sugammadex (Bridion) physically wraps up the drug; neostigmine works around it. Knowing how each behaves keeps you ahead of the two big dangers: bradycardia and recurarization.

Two mechanisms, two personalities

Sugammadex is a modified sugar molecule (a cyclodextrin) that acts like a molecular cage: it wraps around a rocuronium or vecuronium molecule in the plasma, pulls it away from the neuromuscular junction, and the complex is excreted by the kidneys. Because it removes the drug itself, it can reverse even profound block within a few minutes and there's no ceiling the way there is with neostigmine. This selective binding is also why it only works on the aminosteroid paralytics (roc/vec) — it has nothing to grab onto with succinylcholine, cisatracurium, or atracurium.

Neostigmine takes the indirect route. It blocks acetylcholinesterase, so acetylcholine piles up at the junction and out-competes the residual paralytic. That only works once the block has already started to wear off — if too many receptors are still occupied, there aren't enough free receptors for the extra acetylcholine to matter. Give it too deep and you get an incomplete, unreliable reversal. And because the excess acetylcholine hits every muscarinic receptor, neostigmine slows the heart and cranks up secretions, salivation, and gut motility — which is why it is always co-administered with an anticholinergic (glycopyrrolate, sometimes atropine) to protect the heart rate.

The dangers you actually watch for

Sugammadex's specific catches

Two things separate sugammadex from a free lunch. First, it is renally eliminated, so its use in severe kidney disease is cautious and the roc-sugammadex complex clears slowly. Second — and this is a mandatory patient-teaching point — sugammadex binds progestogens and renders hormonal contraception ineffective for about a week. Any patient of reproductive potential must be told to use backup contraception for 7 days, the equivalent of a missed-pill situation. There are also reports of bradycardia and rare anaphylaxis with sugammadex itself, so it isn't monitor-free either.

How the choice gets made

Sugammadex tends to win when the block is deep and needs to come off fast — a can't-intubate emergency where you want the rocuronium gone, a rapid wake-up, or a patient in whom bradycardia or secretions are especially dangerous. Neostigmine remains a reasonable, far cheaper choice when the block is already shallow and the patient is recovering on their own and there's no rush. Either way, the paralytic in play decides eligibility: if it's cisatracurium or succinylcholine, sugammadex is off the table.

Related: Cisatracurium vs succinylcholine · Etomidate vs ketamine (RSI) · Cisatracurium (Nimbex) guide · Precedex vs propofol

Educational content for licensed clinicians. Always follow your facility's pharmacy dosing protocol and provider orders. Not medical advice.